Dicerna Pharmaceuticals Inc

NASDAQ:DRNA   3:59:57 PM EDT
38.12
+0.02 (+0.05%)
Equity Investments, Mergers / Acquisitions

Novo Nordisk To Acquire Dicerna

Published: 11/18/2021 12:34 GMT
Dicerna Pharmaceuticals Inc (DRNA) - Novo Nordisk to Acquire Dicerna.
Dicerna Pharmaceuticals Inc - Deal for $38.25 per Share.
Dicerna Pharmaceuticals Inc - Deal for Total Equity Value of $3.3 Billion.
Dicerna Pharmaceuticals Inc - Transaction Was Unanimously Approved by Dicerna Board of Directors and Board of Directors of Novo Nordisk.
Dicerna Pharmaceuticals Inc - Novo Nordisk, Through a Unit , Will Initiate a Tender Offer to Acquire All Outstanding Shares of Dicerna Common Stock.
Dicerna - Novo Nordisk Expects to Initiate Clinical Development of First Investigational Rnai Therapeutic to Emerge From This Collaboration in 2022.